Martin Gleave, executive director of Vancouver Prostate Centre, said: “Knowing that our two organisations hold similar mandates, this collaboration with CDRD ensures that we are maximising our resources to increase cancer research efforts and creating viable paths of commercialisation for locally developed therapeutics.
“Ultimately, this partnership reflects our shared goals to both improve the lives of cancer patients and support the local biotech community.”
Natalie Dakers, CEO at CDRD, said: “While we have worked with the Vancouver Prostate Centre in the past, the formalisation of this collaboration allows us to seek and initiate specific projects that will benefit from our combined, complementary strengths.
“As two of a select group of organisations that have been named ‘Centres of Excellence in Commercialisation and Research,’ we have found a way to further leverage our funding and expertise to ensure that new cancer therapeutics will be developed and commercialised.”
Vancouver Prostate Centre and CDRD are also working together on an international collaboration with Griffith University’s Eskitis Institute in Queensland, Australia.